Related references
Note: Only part of the references are listed.Potentiation of in Vivo Anticancer Efficacy of Selenium Nanoparticles by Mushroom Polysaccharides Surface Decoration
Delong Zeng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
Ludovic Fournel et al.
CANCER LETTERS (2019)
Mechanisms Controlling PD-L1 Expression in Cancer
Jong-Ho Cha et al.
MOLECULAR CELL (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
Junghoon Shin et al.
CANCER RESEARCH AND TREATMENT (2019)
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
Ioannis Zerdes et al.
ONCOGENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
Peixin Dong et al.
FRONTIERS IN ONCOLOGY (2018)
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
Lu Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Dietary Supplementation with Methylseleninic Acid Inhibits Mammary Tumorigenesis and Metastasis in Male MMTV-PyMT Mice
Sneha Sundaram et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
Linda Tran et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark et al.
CANCER RESEARCH (2016)
Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy
Panpan Zhang et al.
CANCER SCIENCE (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Selenium Exposure and Cancer Risk: an Updated Meta-analysis and Meta-regression
Xianlei Cai et al.
SCIENTIFIC REPORTS (2016)
Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition
Miriam Tarrado-Castellarnau et al.
PHARMACOLOGICAL RESEARCH (2015)
Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk
Alan R. Kristal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Synergistic Induction of Apoptosis by Methylseleninic Acid and Cisplatin, The Role of ROS-ERK/AKT-p53 Pathway
Yibo Zhang et al.
MOLECULAR PHARMACEUTICS (2014)
Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad
Shutao Yin et al.
APOPTOSIS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Chemopreventive effects of early-stage and late-stage supplementation of vitamin E and selenium on esophageal carcinogenesis in rats maintained on a low vitamin E/selenium diet
Hui Yang et al.
CARCINOGENESIS (2011)
Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite
Guang-xun Li et al.
CARCINOGENESIS (2008)
Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin
Hongbo Hu et al.
CLINICAL CANCER RESEARCH (2008)
Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates
Song Li et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Selenium and cancer chemoprevention:: Hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells
JX Lü et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
K Yamaguchi et al.
ONCOGENE (2005)
Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells
HB Hu et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
